Biosynthesis of Isoprenoids: Terpenes (Including Steroids & Carotenoids)
Alan C. Spivey [email protected]
Dec 2014 Format & Scope of Lectures
• What are isoprenoids?
– n × C5 diversity: terpenes, steroids, carotenoids & natural rubber – „the isoprene rule‟ – mevalonate & 1-deoxyxylulose pathways to IPP & DMAPP
• Monoterpnes (C10) – regular („head-to-tail‟) via geranyl pyrophosphate – irregular: incl. iridoids (e.g. seco-loganin)
• Sesquiterpenes (C15) – farnesyl pyrophosphate derived metabolites – sesquiterpene cyclases: pentalenene, aristolochene & 5-epi-aristolochene
• Diterpenes (C20) – gibberellins & taxol
• Triterpenes (C30) – hopanoids (squalene → hopene) – steroids (2,3-oxidosqualene → lanosterol → cholesterol → estrone)
– ring-opened „steroids‟: vitamin D2 & azadirachtin • Biomimetic cationic cyclisation cascades
• Carotenoids (C40) – b-carotene, retinal & vitamin A Isoprenoids • isoprenoids are widely distributed in the natural world – particularly prevalent in plants and least common in insects; >30,000 known
– composed of integral numbers of C5 „isoprene‟ units:
• monoterpenes (C10); sesquiterpenes (C15); diterpenes (C20); sesterpenes (C25, rare); triterpenes (C30); carotenoids (C40)
H O H OH O
OH HO O OH thujone borneol lavandulol HO (C10) (C10) (C10) (Z)--bisabolene humulone (2x C ) 5 (C ) 15 H O O OH H n O 5 ISOPRENOIDS H artemisinin (C15) natural rubber (~10 x C5) O
O OPP OPP OH O OH dimethylallyl isopentenyl pyrophosphate pyrophosphate HO OH (DMAPP) (IPP) euonyminol (C ) b-carotene (C40) 15 OH OH OH H H OH OH AcO O H OH Ph H O gibberellic acid (C20) (gibberellin A ) H H BzHN O HO 3 H CO H HO O 2 HO O HO cholesterol BzO AcO O (C27 but C30-derived) taxol (C20) Historical Perspective – ‘The Isoprenoid Rule’
• Early 1900s:
– common structural feature of terpenes – integral # of C5 units – pyrolysis of many monoterpenes produced two moles of isoprene:
2x 200°C isoprene (C5) -pinene (C10) • 1940s: – biogenesis of terpenes attributed to oligomers of isoprene – ‘the isoprene rule’ • 1953: – Ruzicka proposes „the biogenetic isoprene rule‟ to accomodate „irregular‟ terpenoids: • i.e. that terpenes were derived from a number of biological equivalents of isoprene initially joined in a „head-to-tail‟ manner & sometimes subsequently modified enzymatically to provide greater diversity of structure • 1964: – Nobel prize awarded to Bloch, Cornforth & Popjak for elucidation of biosynthetic pathway to cholesterol including the first steps: • acetate → mevalonate (MVA) → isopentenyl pyrophosphate (IPP) & dimethylallyl pyrophosphate (DMAPP) • 1993: – Rohmer, Sahm & Arigoni elucidate an additional pathway to IPP & DMAPP: • pyruvate + glyceraldehyde-3-phosphate → 1-deoxyxylulose-5-phosphate → IPP & DMAPP
Primary Metabolism - Overview
Primary metabolism Primary metabolites Secondary metabolites
CO2 + H2O
PHOTOSYNTHESIS 1) 'light reactions': hv -> ATP and NADH 2) 'dark reactions': CO2 -> sugars (Calvin cycle)
HO O oligosaccharides HOHO polysaccharides HO nucleic acids (RNA, DNA) OH glycolysis glucose & other 4,5,6 & 7 carbon sugars
CO2 SHIKIMATE METABOLITES PO cinnamic acid derivatives CO2 + aromatic compounds HO HO OH lignans, flavinoids PO O OH OH phosphoenol pyruvate erythrose-4-phosphate shikimate
ALKALOIDS aromatic amino acids peptides penicillins CO 2 proteins cephalosporins aliphatic amino acids cyclic peptides O pyruvate tetrapyrroles (porphyrins) Citric acid cycle (Krebs cycle) saturated fatty acids FATTY ACIDS & POLYKETIDES SCoA SCoA unsaturated fatty acids prostaglandins CO2 lipids polyacetylenes O O acetyl coenzyme A aromatic compounds, polyphenols malonyl coenzyme A macrolides
CoAS O HO ISOPRENOIDS CO2 terpenoids O HO steroids acetoacetyl coenzyme A mevalonate carotenoids Biosynthesis of Mevalonate
• Mevalonate (MVA) is the first committed step of isoprenoid biosynthesis – this key 6-carbon metabolite is formed from three molecules of acetyl CoA via acetoacetyl CoA:
Primary metabolism Secondary metabolism
CO2 pyruvate GLYCOLYSIS O
CoASH CO2 oxidative decarboxylation NAD NADH
SCoA acetyl CoA CITRIC ACID CYCLE O
SCoA acetyl CoA carboxylase O CO2 Claisen CoASH (biotin-dependent) condensation carboxylation CoAS O
aldol O SCoA saturated fatty acids FATTY ACIDS & POLYKETIDES acetoacetyl CoA unsaturated fatty acids reaction CO2 prostaglandins then [R] O lipids polyacetylenes SCoA 2x CoASH malonyl CoA aromatic compounds, polyphenols 2x NADPH macrolides O 2x NADP
HO ISOPRENOIDS CO2 terpenoids HO steroids mevalonate (MVA) carotenoids Biosynthesis of IPP & DMAPP - via Mevalonate
• IPP & DMAPP are the key C5 precursors to all isoprenoids – the main pathway is via: acetyl CoA → acetoacetyl CoA → HMG CoA → mevalonate → IPP → DMAPP:
Claisen condensation CoASH B-Enz SCoA CoAS O SCoA CoAS O SCoA acetoacetyl CoA H O O O O O CoAS acetyl CoA CoAS aldol reaction O
H O 2 CoASH
CoAS HO hydroxymethylglutaryl CoA OPP CO (HMG CoA) H 2 DMAPP D O
IPP isomerase T 2x NADPH 2x NADP HMG CoA reductase (overall anti D2O RDS in cholesterol stereochemistry) CoASH biosynthesis Cys 3x ATP 139 S decarboxylative elimination O OPP D PO Me HO IPP mevalonate (MVA) CO2 H PPO O HO O HR Hs T Pi + CO2 3x ADP Glu 207 O
sequential addition HMG CoA reductase inhibitors - Statins
• HMG CoA → MVA is the rate determining step in the biosynthetic pathway to cholesterol – 33 enzyme mediated steps are required to biosynthesise cholesterol from acetyl CoA & in principle the inhibition of any one of these will serve to break the chain. In practice, control rests with HMG-CoA reductase as the result of a variety of biochemical feedback mechanisms • ‘Statins’ inhibit HMG CoA reductase and are used clinically to treat hypercholesteraemia - a causative factor in heart disease – e.g. mevinolin (=lovastatin®, Merck) from Aspergillus terreus is a competitive inhibitior of HMG-CoA reductase
HO CoAS HO CO2 NADPH Zn2 H CO2 HO R N O CoAS O CO2 H H HO O NADPH HMG CoA H2N NADP NADP mevalonate (MVA) OH CoASH OH CO2 HO H O OH O CO2 i 2 O Pr OH O O O O OH PhHN N LIPITOR in vivo Ph H F mevinolin (=lovastatin®) H H HO ACTIVE DRUG cholesterol PRO-DRUG mimic of tetrahedral intermediate NB. type I (iterative) PKS natural product in HMG reduction by NADPH Biosynthesis of IPP & DMAPP – via 1-Deoxyxylulose • the mevalonate route to IPP & DMAPP has been proven in yeast & animals & in some plants & for a long while was believed to be the only pathway to these key intermediates – However, in some bacterial labelling studies: • no incorporation of mevalonolactone was observed • the pattern of label from glucose was inconsistent with derivation via catabolism to acetate • in 1993 an additional pathway to IPP & DMAPP was discovered: – Rohmer et al. Biochem. J. 1993, 295, 517 (DOI)
OH DXP NADPH OH CO2 O OH O OH H synthase + O H HO O OP OH OP pyruvate OH OP OH OP CO2 NADP glyceraldehyde 1-deoxyxylulose DXP 2-methyerythritol 3-phosphate 5-phosphate (DXP) reducto- 4-phosphate isomerase ATP + CTP
ADP + PPi OPP DMAPP NADPH NH2 NADPH OH OH O N OPP HO HO P O HO O O P O OP O O O N O OPP P P IPP NADP O O O 4-hydroxy-DMAPP CMP O O O O NADP
OH OH NB. CMP = cytidine monophosphate CTP = cytidine triphosphate cytosine
• The pathway is prevalent in many pathogenic bacteria and so its inhibition represents an exciting opportunity for antiinfective therapeutic development: Rohdich J. Org. Chem. 2006, 71, 8824 (DOI) Chorismate → Coenzymes Q & Vitamins E & K
• Chorismate → p- & o-hydroxybenzoic acids → coenzymes Q & vitamins E & K – NB. ‘Mixed’ biosynthetic origin: shikimate/mevalonate (isoprenoid)
H O C CO2 CO2 2 CO2 H H O O CO2 OH OH O O 3 O 3
H OH 1 2 CO2 CO2 R , R = H or Me CO2 isoprenoid 1 2 prephenate R R OH OH OH OH OH homogentisate tocopherols (vitamins E) electron transport, antioxidant ArC1
CO2 OH2 CO2 CO2 O isoprenoid MeO Me
O CO2 ubiquinones (coenzymes Q) H OH R MeO R MeO H lipid-soluble electron transport CO n chorismate 2 OH OH OH O O R ArC0 pyruvate
-ketoglutarate (KG) KG H R isoprenoid O SCoA n CO2 R CO O C CO 2 2 2 OH O Me O OH O menaquinones (vitamins K) CO2 cofactors for plasma proteins O O essential for blood clotting O HO O CO2 CO ArC1 isochorismate 2 CO2 O Hemi-Terpenes – ‘Prenylated Alkaloids’
• DMAPP is an excellent alkylating agent
• C5 units are frequently encountered as part of alkaloids (& shikimate metabolites) due to „late- stage‟ alkylation by DMAPP – the transferred dimethyl allyl unit is often referred to as a ‘prenyl group’
– ‘normal prenylation’ – ‘SN2’-like alkylation; ‘reverse prenylation’ – ‘SN2’-like alkylation
• e.g. lysergic acid (recall the ergot alkaloids) – a „normal prenylated‟ alkaloid (with significant subsequent processing) • e.g. roquefortine (recall diketopiperazine alkaloids) – a „reverse prenylated‟ alkaloid
DMAPP histidine O H OPP OPP Me O HO N DMAPP H 'reverse' 'normal' H N prenylation NH prenylation 4 3 tyrosine N N
tyrosine cf. SN2' N H cf. S 2 H O N N N N H H H roquefortine (blue cheese mould) lysergic acid (halucinogen)
– review: R.M. Williams et al. ‘Biosynthesis of prenylated alkaloids derived from tryptophan’ Top. Curr. Chem. 2000, 209, 97-173 (DOI) Linear C5n „head-to-tail‟ Pyrophosphates
• head-to-tail C5 oligomers are the key precursors to isoprenoids – geranyl pyrophosphate (C10) is formed by SN1 alkylation of DMAPP by IPP → monoterpenes – farnesyl (C15) & geranylgeranyl (C20) pyrophosphates are formed by further SN1 alkylations with IPP:
via OPP inversion OPP SN1 H OPP HR H* OPP
DMAPP HS
OPP *H H OPP evidence for S 1: N OPP MONOTERPENES (C10)
HS HR OPP intimate ion pair gerenyl pyrophosphate (C ) OPP 10 IPP F C F C 3 3 IPP ionisation is 1,000,000 times slower OPP
SESQUITERPENES (C15) TRITERPENES (C30) farnesyl pyrophosphate (C15)
IPP OPP
DITERPENES (C20) CAROTENOIDS (C40) gerenylgeranyl pyrophosphate (C20) Monoterpenes from Parsley & Sage
apiol -pinene Parsley (Petroselinum sativum)
camphene thujone Sage (Salvia officinalis) Monoterpenes from Rosemary & Thyme
camphor borneol cineol Rosemary (Rosmarinus officinalis)
Thyme (Thymus vulgaris) thymol carvacrol Limonene & Carvone
Chiroscience plc. (now Dow Inc.)
1. S-(-)-limonene (lemon) 4. R-(-)-carvone (spearmint)
2. R-(+)-limonene (orange) 5. S-(+)-carvone (caraway)
3. RS-(±)-limonene (pleasant) 6. RS-(±)-carvone (disgusting) Monoterpenes – -Terpinyl Cation Formation
• geranyl pyrophosphate isomerises readily via an allylic cation to linalyl & neryl pyrophosphates – the leaving group abilty of pyrophosphate is enhanced by coordination to 3 × Mg2+ – all three pyrophosphates are substrates for cyclases via an -terpinyl cation:
OPP (E) O O Mg O P O P O O O gerenyl Mg pyrophosphate
OPP
linalyl pyrophosphate
OPP (Z) OPP cyclase
= MONOTERPENES (C10) OPP neryl pyrophosphate initial chiral centre -terpinyl cation allylic cation intimate ion pair Monoterpenes – Fate of the -Terpinyl Cation
• The -terpinyl cation undergoes a rich variety of further chemistry to give a diverse array of monoterpenes • Some important enzyme catalysed pathways are shown below – NB. intervention of Wagner-Meerwein 1,2-hydride- & 1,2-alkyl shifts
limonene -terpineol hydrolysis [O] trapping by PPO- H H OH OH OPP OPP O bornyl borneol camphor E1 elimination trapping with pyrophosphate a b water =
c OPP OPP trapping by alkene H E elimination c 1 = d at 'red' carbon 1,2-alkyl shift c d (anti-Markovnikov) H e = camphene b trapping by alkene H2O at 'blue' carbon (Markovnikov) a -terpinyl cation E1 elimination H d = H H = 1,2-hydride shift e = b-pinene H O H E1 elimination = =
-pinene H thujone Irregular Monoterpenes
• Non-‟head-to-tail‟ linkage of IPP &/or DMAPP leads to ‘irregular’ monoterpenes – e.g. daisy (Compositae) & chrysanthemum metabolites:
[O] H H OH CO2H chrysanthemic acid H O 2 Enz-B: O OPP a [O] HH b OPP OPP OPP a 2x DMAPP artemisia ketone cyclopropylmethyl cations are relatively stable because of the high p-character of the -bonds
b
H O 2 HO
santolina alcohol
– Natural crysanthemic acid derivatives are referred to as pyrethrins and are natural insecticides – Synthetic analogues of crysanthemic acid are referred to as pyrethroids. e.g. bifenthrin:
Cl O Bifenthrin F3C potent insecticide (via ATPase inhibition) O Apparently Irregular Monoterpenes
• apparently ‘irregular’ monoterpenes can also occur by non-cationic cyclisation of geranyl PP derivatives followed by extensive rearrangement – e.g. iridoids – named after Iridomyrmex ants but generally of plant origin and invariably glucosidated • e.g. seco-loganin (recall indole alkaloids) is a key component of strictosidine - precorsor to numerous complex medicinally important alkaloids:
H2O H OPP OPP O O 2x NADP NADPH [O] OH = O
P450 OH O OH 2x NADPH O NADP OH 10 10 [O] PP geranyl PP i 10-oxo geranal P450
unusual reductive ring-closure -> cyclopentane (NB. Non-cationic) OH
O HO2C NH2 [O] P450 glycoside N H formation H tryptamine O ATP N NH HO HO [O] P OP 450 tryptophan H H H H H OGlu OGlu OGlu OGlu OGlu methylation H H O H SAM isoprene O O ADP O O MeO C H2O MeO2C H O MeO C HO C 2 2 MeO2C 2 2 strictosidine secologanin loganin enzymatic Pictet-Spengler unusual fragmentation reaction Strictosidine → Vinca, Strychnos, Quinine etc.
• The diversity of alkaloids derived from strictosidine is stunning and many pathways remain to be fully elucidated:
N OH N N H H H N H N H N H H N O H H H MeO2C MeO2C N OAc ajmalicine H MeO H OH Me (vinca) CO2Me MeO2C vinblastine OH (vinca) yohimbine MeO O N N H N 3 NH O N H H H H OGlu N H OH O H O aspidospermine camptothecin MeO2C (vinca) H strictosidine (isovincoside) N H N Me HO H MeO N H O N H H N O H O quinine N O H strychnine (strychnos) gelsemine (oxindole) Sesquiterpenes – Farnesyl Pyrophosphate (FPP)
• ‘SN2’-like alkylation of geranyl PP by IPP gives farnesyl PP:
pro-R hydrogen is lost OPP OPP HS HR OPP OPP (E) (E) geranyl PP IPP E,E-farnesyl PP (FPP)
• just as geranyl PP readily isomerises to neryl & linaly PPs so farnesyl PP readily isomerises to equivalent compounds – allowing many modes of cyclisation & bicyclisation
OPP (E) (E) O O Mg O O P P O E,E-FPP O O Mg
- further cyclisation (E) 6-memb - 1,2-hydride & alkyl shifts (Z) cyclases vast array of 10-memb mono- & bicyclic 11-memb SESQUITERPENES ring cyclised E,Z-FPP OPP - trapping with H2O 'CATIONS' - elimination to alkenes
OPP NB. control by: 1) enzyme to enforce conformation & sequestration of reactive intermediates nerolidyl PP 2) intrinsic stereoelectronics of participating orbitals allylic cation intimate ion pair Sesquiterpene Cyclases
Christianson et al. Curr. Opin. Struct. Biol. 1998, 695 (DOI) Terpene Cyclases – Control of Cyclisation
• Functional aspects of terpenoid cyclases:
– Templating: Active site provides a template for a specific conformation of the flexible linear isoprenoid starting material. – Triggering: Cyclase initiates carbocation formation. • Metal-assisted leaving group departure (e.g. pyrophosphate ionization aided by Mg2+) • C=C bond protonation (e.g. squalene-hopene cyclase, see later). • Epoxide protonation (e.g. oxidosqualene cyclase, see later). – Chaperoning: Chaperones conformations of carbocationic intermediates through the reaction sequence, ordinarily leading to one specific product. – Sequestering: Sequesters the carbocation intermediates by burying the substrate in a hydrophobic cavity that is generally solvent-inaccessible. Carbocations are concomitantly stabilized by the presence of aromatic residues in the active site that exert their effects via cation-p interactions
R cation - p on edges stabilisation RECALL: = on faces -1 R R (~40-80 kJmol ) Enz – Adapted from: Christianson et al. Curr. Opin. Struct. Biol. 1998, 695 (DOI)
• BUT: – individual terpene cyclases can give multiple products, see: Matsuda J. Am. Chem. Soc. 2007, 129, 11213 (DOI)
Sesquiterpene Cyclase Crystal structures
pentalenene synthase 5-epi-aristolochene synthase aristolochene synthase
→ pentalenolactone (antibiotic) → fungal (myco)toxins (e.g. bipolaroxin, PR-toxin) Aristolochene & 5-Epi-Aristolochene Synthases
• molecular modelling studies indicate that the shape of the active sites determines the conformation of FPP and thus the stereochemistry of the final product
– Penicillium roqueforti aristolochene synthase – Felicetti & Cane J. Am. Chem. Soc. 2004, 126, 7212 (DOI)
– tobacco 5-epi-aristolochene synthase – Starks, Back, Chappell & Noel Science 1997, 277, 1815 (DOI)
Diterpenes - Gibberellins
Dwarf rice seedlings (on the left) have a defect in the gibberellin- dependent signalling mechanism
gibberellin A20 effects of gibberellin A1 and brassinolide on rice seedlings Diterpenes – Geranylgeranyl Pyrophosphate
• SN2 alkylation of farnesyl PP by IPP gives geranylgeranyl PP:
OPP OPP H H OPP OPP
FPP IPP gerenylgeranyl PP (C ) 20 • geranylgeranyl PP readily cyclises to give numerous multicyclic diterpenes – e.g. gibberellins – plant growth hormones • NB. cyclisation initiated by alkene protonation NOT loss of PPO-
1,2-alkyl H OPP bicyclisation OPP cyclisation cyclisation shift
H H H H H 6-endo 6-exo 6-endo H H H H H gera nylgeranyl PP labdadienyl PP
elimination
H OH H pinacol 4x [O] H O rearrangement (?) H HO
CO H H O 2 H H OH gibberellic acid HO C CHO H 2 HO2C OP kaurene (gibberellin A3)
• review: L.N. Mander „Twenty years of gibberellin research‟ Nat. Prod. Rep. 2003, 20, 49-69 (DOI) Diterpenes - Taxol Diterpenes – Geranylgeranyl PP → Taxol
• Taxol is a potent anti-cancer agent used in the treatment of breast & ovarian cancers – comes from the bark of the pacific yew (Taxus brevifolia) – binds to tubulin and intereferes with the assembly of microtubules • biosynthesis is from geranylgeranyl PP:
cembrene
a cyclisation b AcO 14-exo O sesquiterpene H OH OPP a b Ph (isoprenoid) H BzNH O geranylgeranyl PP H taxol OPP HO O HO BzO AcO O
b-amino acid (shikimate)
– for details see: http://www.chem.qmul.ac.uk/iubmb/enzyme/reaction/terp/taxadiene.html – home page is: http://www.chem.qmul.ac.uk/iubmb/enzyme/ • recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzyme-Catalysed Reactions • based at Department of Chemistry, Queen Mary University of London Triterpenes – FPP → Squalene
OPP • triterpenes (C30) arise from the ‘head to head’ coupling of two fanesyl PP units to give FPP (acceptor) OPP squalene catalysed by squalene synthase: FPP (donor) EnzB: H H – squalene was first identified as a steroid precursor OPP from shark liver oil
OPP – the dimerisation proceeds via an unusual mechanism squalene synthase blocked by squalestatins
involving electrophilic cyclopropane formation - H rearrangement to a tertiary cyclopropylmethyl cation presqualene PP and reductive cyclopropane ring-opening by NADPH (NB. exact mechanism disputed) OPP
H – Zaragozic acids (squalestatins) mimic a H rearrangement intermediate and inhibit squalene synthase. They constitute interesting leads for OPP development of new treatments for NADPH hypercholesteraemia & heart disease (cf. statins) NADP + PPi H H O squalene O OH OAc HO C 2 O zaragozic acid A HO2C O (squalestatin S1) For an interesting account of the elucidation of this pathway see: OH CO2H Poulter J. Org. Chem. 2009, 74, 2631 (DOI) Triterpenes – Squalene → 2,3-Oxidosqualene
• squalene is oxidised to 2,3-oxidosqualene by squalene oxidase – which is an O2/FADH2- dependent enzyme: squalene oxidase
O2 + FADH2
O
squalene H2O + FAD 2,3-oxidosqualene
• the key oxidant is therefore a peroxyflavin:
reductive recycling
H H H O N O O N O O N O H O O N O O O HO NH O NH N HN HN H N N N NR NR NR NR H2O O
FADH 2 peroxyflavin hydroxyflavin FAD Modes of Cyclisation of Squalene
• all triterpenes (steroids, hopanoids etc.) are formed by the action of cyclase enzymes on either squalene or 2,3-oxidosqualene – i.e. different methods of ‘triggering’ cyclisation
OH H H H squalene OH cyclases H H H HOPANOIDS triggering by H H H ALKENE protonation H H hopene diplopterol H tetrahymanol squalene squalene oxidase
H H oxidosqualene H cyclases H STEROIDS triggering by H O EPOXIDE protonation HO HO HO H b-amyrin H cycloartenol H lanosterol 2,3-oxidosqualene
STEROID/TRITERPENE NOMENCLATURE: b-face = top face (as drawn here) = hydrogen up = hydrogen down -face = bottom face (as drawn here) (on b-face) (on -face) Squalene-Hopene Cyclase (SHC)
• Squalene-Hopene Cyclase (SHC) catalyses the formation of hopene from squalene: – what does the enzyme have to do to achieve such exquisite regio- & stereoselectivity over the formation of 9 new stereogenic centres? • enforce an appropriate conformation of squalene • activate the C2 alkene by protonation
• shield reactive cations from nucleophiles (e.g. H2O) using aromatic residues (cation-p) • position a general base precisely to facilitate the terminal elimination
– until recently, the „appropriate‟ conformation was believed to be the formally appealing ‘all-chair’ conformation allowing for a concerted cationic ring-closure cascade (shown below) – remaining stereocontrol would then be taken care of by intrinsic stereoelectronics • i.e. correct orbital overlap
– however, this requires anti-Markovnikov regioselectivity for the C & D ring-closures...
C & D ring-closure by 2x anti-Markovnikov additions? H
H SHC C D EnzB-H H H 5x ring-closures :BEnz H 6-endo, 6-endo, 6-endo, 6-endo, 5-endo ? squalene hopene via chair-chair-chair-chair conformation ? Squalene-Hopene Synthase (SHC)
H
squalene H+ 6-endo 6-endo 6-endo ? 6-endo 5-endo
hopene
X-ray crystal structure: Wendt, Poralla & Schulz Science, 1997, 277, 1811 (DOI) Squalene-Hopene Synthase - Mechanism
• The process is apparently more complex & has more recently been shown to involve: – 2x Markovnikov ring-closure/1,2-alkyl-shift ring-expansion sequences to establish the C & D rings – lessons? • the conformation enforced by the enzyme is NOT strictly an all-chair one! (although probably very close) • the process is NOT concerted, discrete cationic intermediates are involved • stereoelectronics dictate the regio- & stereoselectivity
Markovnikov ring expansion 1) alkene protonation ring-closure (5 -> 6) (5-memb ring) EnzB-H H 1,2-alkyl shift H 5-endo 2) 2x Markovnikov ring-closures squalene (6-memb rings) 6-endo, 6-endo Markovnikov 5-endo ring-closure (5-memb ring) :BEnz H H ring H Markovnikov H H expansion ring-closure H H (5 -> 6) E1 elimination (5-memb ring) H 1,2-alkyl shift H 5-endo H H
H H hopene
– review: Wendt et al. Angew. Chem. Int. Ed. 2000, 39, 2812 (DOI) & Wendt ibid 2005, 44, 3966 (DOI) Oxidosqualene-Lanosterol Cyclase (OSC)
• oxidosqualene-lanosterol cyclase catalyses the formation of lanosterol from 2,3-oxidosqualene: – this cascade establishes the characteristic ring system of ALL steroids – until recently, as for SHC, the enzyme was believed to enforce a chair-boat-chair conformation to allow a concerted cationic ring-closure cascade followed by a series of suprafacial 1,2-shifts (shown below)
– however, this also requires anti-Markovnikov regioselectivity for the C ring-closure...
C ring-closure by anti-Markovnikov addition?
O OSC 6-endo, 6-endo, 6-endo, 5-endo ? 4x ring-closures EnzB-H chair-boat-chair conformation ? O
2,3-oxidosqualene
H H H prosterol cation C HO 2x 1,2-hydride shifts 2x 1,2-Me shifts NB all bolded bonds are anti-peri planar H HO elimination H lanosterol Oxidosqualene-Lanosterol Cyclase – Mechanism
• This process has also been shown to involve a Markovnikov ring-closure/1,2-alkyl-shift ring- expansion sequence to establish the C ring – again, the conformation enforced by the enzyme is NOT strictly a chair-boat-chair one (although probably close), the process is NOT concerted, discrete cationic intermediates are involved & stereoelectronics dictate the regio- & stereoselectivity
Markovnikov ring 1) epoxide opening ring-closure expansion (5-memb ring) (5 -> 6) H 1,2-alkyl shift 2) 2x Markovnikov 5-endo H H ring-closures HO EnzB-H O HO HO (6-memb rings) Markovnikov 6-endo, 6-endo 2,3-oxidosqualene 5-endo ring-closure (5-memb ring)
1) 1,2-hydride shift H H H H 2) 1,2-hydride shift E1 elimination
3) 1,2-Me shift H H 4) 1,2-Me shift HO HO HO :BEnz (ALL suprafacial) H H H lanosterol protosterol cation
– “The enzyme’s role is most likely to shield intermediate carbocations… thereby allowing the hydride and methyl group migrations to proceed down a thermodynamically favorable and kinetically facile cascade” • Wendt et al. Angew. Chem. Int. Ed. 2000, 39, 2812 (DOI) & Wendt ibid 2005, 44, 3966 (DOI) Lanosterol → Cholesterol – Oxidative Demethylation • Several steps are required for conversion of lanosterol to cholesterol: Cholesterol → Human Sex Hormones
• cholesterol is the precursor to the human sex hormones – progesterone, testosterone & estrone
– the pathway is characterised by extensive oxidative processing by P450 enzymes – estrone is produced from androstendione by oxidative demethylation with concomitant aromatisation:
OH OH O O 2x O P O P NAD H 2 450 H 2 450 H H H H H H
H H H H O H H H H 2x H2O NADH HO HO HO O cholesterol progesterone
[O]
X O III Fe O O EnzB: O H H O OH 2 P450 O 2x O2 P450 H H H H H H H H H O HO HCO H 2 O O androstendione (X = O) estrone 2x H2O (œstrone) testosterone (X = H, bOH) DEMETHYLATIVE aromatisation by 'aromatase' enzyme
NB. The involvement of a peroxyacetal during aromatase demethylation has recently been disputed, see: Guengerich J. Am. Chem. Soc. 2014, 136, 15036 (DOI). Steroid Ring Cleavage - Vitamin D & Azadirachtin
7 • vitamin D2 is biosynthesised by the photolytic cleavage of -dehydrocholesterol by UV light: – a classic example of photo-allowed, conrotatory electrocyclic ring-opening:
– D vitamins are involved in calcium absorption; defficiency leads to rickets (brittle/deformed bones)
• Azadirachtin is a potent insect anti-feedant from the Indian neem tree: – exact biogenesis unknown but certainly via steroid modification:
O MeO C OAc O 2 H O OH O H O OH 12 O O C 11 O 14 OH oxidative 8 O H 7 cleavage highly hindered C-C bond HO OH AcO OH AcO OH for synthesis! H H of C ring H MeO2C O AcO H tirucallol azadirachtanin A azadirachtin (cf. lanosterol) (a limanoid = tetra-nor-triterpenoid) Biomimetic Cationic Cyclisations - Progesterone
• in 1971, W.S. Johnson utilized a biomimetic polyolefin cyclization in a pioneering & elegant total synthesis of the hormone progesterone – the substrate‟s preference for the ‘chair-chair-chair’ conformation provided the progesterone core with impressive stereoselectivity – the cascade was initiated by protonation of a tert-alcohol
O O O O O O O O O H
Cl(CH ) Cl 2 2 H H K CO o 2 3 TFA, 0 C H2O, MeOH OH [72%] H
O O O 1) O3, MeOH o CH2Cl2, -70 C H H H H2O/5% KOH, rt 2) Zn, AcOH H H H H [51%] H H [88%] O O O progesterone
– Johnson, Gravestock & McCarry J. Am. Chem. Soc. 1971, 93, 4332 (DOI) Biomimetic Cationic Cyclisations – Enantioselective
• Yamamoto has achieved several enantioselective cationic cascade cyclisations using a chiral
„Lewis acid assisted Brønsted acid‟ (LBA) prepared by mixing binol & SnCl4:
1) (R)-LBA (2eq) toluene, -78°C, 3d = . H H 2) BF OEt H 3 2 MeNO2 H H [65%, 77% ee] O SnCl O 4 iPr
(R)-LBA OH (R)-LBA (2eq) CH Cl , -78°C, 3d O = O H 2 2 O = H H [56%, 42% ee] H + minor diastereomers
– Yamamoto et al. J. Am. Chem. Soc., 1999, 121, 4906 (DOI) – Yamamoto et al. J. Am. Chem. Soc. 2001, 123, 1505 (DOI) Carotenoids – b-Carotene & vitamin A1
• Carotenoids (C40) are coloured pigments made by photosynthetic plants & certain algae, bacteria & fungi. Dietary ingestion by birds and further processing gives rise to bright feather pigments etc. – biosynthesised by head-to-head coupling of two geranylgeranyl PP units to give lycopersene:
OPP
GGPP (acceptor) OPP GGPP (donor) prephytoene synthase
H prephytoene PP (cf. presqualene PP) PPO NADPH NADP + PPi
lycopersene
[O]
b-carotene
– subsequent oxidative degradation (cf. ozonolysis!) gives retinal (mediator of vision) & vitamin A1:
11 (E) O OH
retinal vitamin A1 Primary Metabolism - Overview
Primary metabolism Primary metabolites Secondary metabolites
CO2 + H2O
PHOTOSYNTHESIS 1) 'light reactions': hv -> ATP and NADH 2) 'dark reactions': CO2 -> sugars (Calvin cycle)
HO O oligosaccharides HOHO polysaccharides HO nucleic acids (RNA, DNA) OH glycolysis glucose & other 4,5,6 & 7 carbon sugars
CO2 SHIKIMATE METABOLITES PO cinnamic acid derivatives CO2 + aromatic compounds HO HO OH lignans, flavinoids PO O OH OH phosphoenol pyruvate erythrose-4-phosphate shikimate
ALKALOIDS aromatic amino acids peptides penicillins CO 2 proteins cephalosporins aliphatic amino acids cyclic peptides O pyruvate tetrapyrroles (porphyrins) Citric acid cycle (Krebs cycle) saturated fatty acids FATTY ACIDS & POLYKETIDES SCoA SCoA unsaturated fatty acids prostaglandins CO2 lipids polyacetylenes O O acetyl coenzyme A aromatic compounds, polyphenols malonyl coenzyme A macrolides
CoAS O HO ISOPRENOIDS CO2 terpenoids O HO steroids acetoacetyl coenzyme A mevalonate carotenoids